India to South Africa: Atazanavir Export Trade Route

The India to South Africa Atazanavir corridor is one of India's established pharmaceutical export routes, with 27 shipments documented worth a combined $4.2M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 56% of all export value, reflecting the consolidated nature of India's atazanavir manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $156.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with atazanavir's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 21.6%, placing it at rank #6 among India's top atazanavir export destinations globally.

On the import side, key buyers of Indian atazanavir in South Africa include MEDPRO PHARMACEUTICA (PTY) LTD,, EMCURE PHARMACEUTICALS SA (PTY) LTD, VIATRIS HEALTHCARE (PTY) LTD, and 7 others. MEDPRO PHARMACEUTICA (PTY) LTD, is the single largest importer with 3 shipments valued at $2.3M USD.

India's atazanavir exports to South Africa are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, EMCURE PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED — together account for 90% of total trade value on this route. The average shipment value of $156.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as tarito 300/100 tablet (atazanavir 300mg+ ritonavir 100mg) (4771 packs x 1x30s=143130 nos) and tarito 300/100 tablet (atazanavir 300mg+ ritonavir 100mg) (4726 packs x 1x30s=141780 nos), suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MEDPRO PHARMACEUTICA (PTY) LTD, is the largest importer with 3 shipments worth $2.3M USD — representing 53% of all atazanavir imports from India on this route. A total of 10 buyers are active on this corridor.